Cargando…
Gonadotropin-releasing Hormone Agonist Plus Aromatase Inhibitor in the Treatment of Uterine Leiomyoma in Near Menopause Patient: A Case Series Study
OBJECTIVES: There are many drugs for of symptomatic fibroids. Gonadotropin-releasing hormone (GnRH) agonists are the well known drugs. Also, aromatase inhibitors are effective. All published studies surveyed the effect of one of these two drugs. In this study as the first study decided to evaluate t...
Autor principal: | Moradan, Sanam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Menopause
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949310/ https://www.ncbi.nlm.nih.gov/pubmed/29765929 http://dx.doi.org/10.6118/jmm.2018.24.1.62 |
Ejemplares similares
-
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia
por: Chen, Junyu, et al.
Publicado: (2022) -
The efficacy of gonadotropin-releasing hormone agonist treatment before hysteroscopic myomectomy for large-sized submucosal leiomyoma
por: Park, Mia, et al.
Publicado: (2022) -
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series
por: Zagouri, F, et al.
Publicado: (2013) -
Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011) -
A Comparison of Outcomes from In Vitro Fertilization Cycles
Stimulated with Follicle Stimulating Hormone Plus either
Recombinant Luteinizing Hormone or Human Menopausal
Gonadotropins in Subjects Treated with Long Gonadotropin
Releasing Hormone Agonist Protocols
por: Bleau, Nathalie, et al.
Publicado: (2017)